Health care overhaul doubts ease for insurers
Health insurers such as WellPoint Inc. entered last fall cautious about a major coverage expansion initiated by the health care overhaul, but are finding the challenges more manageable than expected.
Health Care
Articles
Eli Lilly donates $12.7 million to United Way
The donation represents the giving of employees and retirees of Lilly and Elanco Animal Health in the U.S. and Puerto Rico, plus a matching contribution from the Lilly Foundation.
Central Indiana doctor faces prescription drug charges
Dr. Eric Jones of Pendleton was arrested Tuesday at his general family practice about 25 miles northeast of Indianapolis.
Takeda, Lilly win 99-percent cut in Actos damages award
Judge Rebecca Doherty in Lafayette, Louisiana, said the jury’s decision to order Takeda to pay $6 billion and Lilly $3 billion was excessive and should be reduced to a total of $36.8 million.
Seals Ambulance sells to Tennessee firm
Seals Ambulance, with 325 workers and nearly $13 million in revenue, will be acquired by Priority Ambulance, but keep its local leadership and name.
Lilly adds $375M to Zymeworks partnership
Eli Lilly and Co. and Zymeworks said Wednesday that they are expanding a cancer drug development partnership.
Hendricks Regional Health dangling 15-percent discounts
Hendricks Regional Health is taking a revolutionary step—at least for the health care industry—by applying the retailer’s playbook. Health care executives say more hospital systems are likely to follow suit in the future.
Zimmer profit beats forecasts, shares rise 4 percent
Shares of Warsaw-based orthopedic device maker Zimmer Holdings Inc. have doubled the performance of the S&P 500 so far this year.
Purdue getting regional nutrition, obesity center
The U.S. Department of Agriculture has chosen Purdue University to be the site of one of four centers, also to include Colorado State University, Cornell University and the University of North Carolina.
Lilly third-quarter earnings fall below Wall Street’s expectations
The Indianapolis drugmaker's profit tumbled 58 percent as cheaper generic medicines took sales from blockbusters Cymbalta and Evista.
Hilton North closure to cost 46 employees their jobs
Community Health Network Foundation is closing the hotel in December to create room for more hospital development.
Thousands affected by Medicaid eligibility change
A change in how eligibility for Medicaid is determined could save Indiana $26 million this fiscal year by pushing thousands of residents off coverage but providing first-time benefits to even more at lower costs.
State settles with drug maker over Medicaid fraud charges
The Indiana attorney general’s office has recovered more than $181,000 for the state Medicaid program by joining with other states and the federal government in a fraud settlement.
Nursing home chain to pay $38M in U.S. settlement
The Justice Department accused Extendicare Health Services Inc. of substandard care between 2007 and 2013 in 33 nursing homes in eight states, including Indiana.
Pence confident Hoosier health workers can handle Ebola
Gov. Mike Pence appeared on a webcast with health care workers Thursday to talk about Ebola and the state’s preparations should the disease arrive in the state.
Hospitals in quest to shrink emergency room visits
Hospitals around the state have been trying to cut emergency room visits—and Obamacare was supposed to help. But the results have been mixed, according to some local hospitals.
Pence names Adams Indiana’s health commissioner
Gov. Mike Pence has named Indianapolis anesthesiologist Dr. Jerome Adams to be commissioner of the Indiana State Department of Health.
Wal-Mart cuts health benefits for most part-timers
Starting Jan. 1, Wal-Mart will no longer offer health insurance to employees who work less than an average of 30 hours a week. The move, which would affect 30,000 employees, follows similar decisions by Target, Home Depot and others.
Pence asks HHS for alternative Medicaid approval
The governor met with Health and Human Services Secretary Sylvia Burwell on Monday in Washington, D.C., but said no deal has been reached yet.
Lilly partner ordered to pay more than $2M to ex-Actos user
Takeda Pharmaceutical Co. was ordered by a jury to pay more than $2 million to a woman who claimed the company’s Actos diabetes medicine caused her bladder cancer, in the latest of thousands of lawsuits involving the drug to go to trial.